SAKTHIRAJ SUBRAMANIAN: Open Payments
NPI 1669676326 · WILLOW PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 44 payments from 10 companies in 2025. Trend: 2023 $588 · 2024 $634 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $195 |
| Novo Nordisk Inc | 11 | $159 |
| Dexcom, Inc. | 1 | $150 |
| Lilly USA, LLC | 9 | $141 |
| AstraZeneca Pharmaceuticals LP | 8 | $136 |
| Phathom Pharmaceuticals, Inc. | 2 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Aimmune Therapeutics, Inc. | 1 | $89 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: DEXCOM G7 GSS (161), JARDIANCE, SKYRIZI, VOQUEZNA, ZENPEP, MOUNJARO, QULIPTA, BREZTRI.
Industry payments across TX — which companies pay providers there.
